SeekingAlpha · Sep 16, 2026
AirSculpt Technologies: Weakness Extends Into Q3 2026
AirSculpt Technologies is a Sell due to missed 2Q26 earnings and a challenging macro environment suppressing cosmetic demand. Read more on AIRS stock here.
NASDAQ · AIRS
Healthcare · Medical - Care Facilities
$1.20
Down-$0.02 (-1.67%)
Updated Oct 26, 2026, 3:50 PM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AIRS
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
AIRS closed at $1.20 after 20 trading sessions, down 36.17% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $1.25 | $1.25 | $1.19 | $1.20 | 251.62K |
| Oct 22, 2026 | $1.265 | $1.275 | $1.15 | $1.25 | 1.31M |
| Oct 21, 2026 | $1.31 | $1.3599 | $1.25 | $1.28 | 603.45K |
| Oct 20, 2026 | $1.26 | $1.35 | $1.21 | $1.30 | 591.35K |
| Oct 19, 2026 | $1.31 | $1.31 | $1.155 | $1.245 | 1.2M |
| Oct 16, 2026 | $1.43 | $1.43 | $1.24 | $1.275 | 1.15M |
| Oct 15, 2026 | $1.43 | $1.44 | $1.38 | $1.415 | 502.22K |
| Oct 14, 2026 | $1.59 | $1.5993 | $1.41 | $1.42 | 809.08K |
| Oct 13, 2026 | $1.65 | $1.675 | $1.6001 | $1.62 | 626.69K |
| Oct 12, 2026 | $1.60 | $1.70 | $1.586 | $1.63 | 735.83K |
| Oct 9, 2026 | $1.65 | $1.685 | $1.59 | $1.62 | 1.02M |
| Oct 8, 2026 | $1.80 | $1.80 | $1.65 | $1.655 | 1.11M |
| Oct 7, 2026 | $1.82 | $1.90 | $1.78 | $1.82 | 877.92K |
| Oct 6, 2026 | $1.95 | $2.025 | $1.845 | $1.86 | 724.57K |
| Oct 5, 2026 | $1.81 | $1.96 | $1.805 | $1.91 | 832.38K |
| Oct 2, 2026 | $1.74 | $1.85 | $1.72 | $1.77 | 886.66K |
| Oct 1, 2026 | $1.74 | $1.81 | $1.635 | $1.70 | 1.41M |
| Sep 30, 2026 | $1.84 | $1.85 | $1.68 | $1.76 | 1.13M |
| Sep 29, 2026 | $1.87 | $1.95 | $1.78 | $1.80 | 731.34K |
| Sep 28, 2026 | $1.91 | $1.9604 | $1.8534 | $1.88 | 788.46K |
The latest Smart Investors Daily articles mentioning AIRS.
Company
Market Activity
Research & News
AIRS research
Company profile and research snapshot.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 31, 2025 | Leerink Partners | Market Perform | — |
| Jan 17, 2025 | Piper Sandler | Neutral | — |
| Jan 6, 2025 | Piper Sandler | Neutral | — |
| Oct 17, 2024 | BTIG | Neutral | — |
| May 14, 2024 | Leerink Partners | Market Perform | — |
No generated briefing is available yet.
SeekingAlpha · Sep 16, 2026
AirSculpt Technologies is a Sell due to missed 2Q26 earnings and a challenging macro environment suppressing cosmetic demand. Read more on AIRS stock here.
Yahoo · Sep 5, 2026
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
SeekingAlpha · Aug 10, 2026
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call August 10, 2026 8:30 AM EDTCompany ParticipantsYogesh Jashnani - CEO & DirectorMichael Arthur...
Benzinga · Aug 10, 2026
AirSculpt Technologies (NASDAQ:AIRS) narrows FY2026 sales outlook from $151.000 million-$157.000 million to $151.000 million vs $153.185 million estimate.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning AIRS.